SG Americas Securities
MBX

SG Americas Securities’s MBX Biosciences MBX Stock Holding History

SG Americas Securities’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
6,245
+2,859
+84% +$99.9K ﹤0.01% 2517
2026
Q1 		$101K Sell
3,386
-1,379
-29% -$46.9K ﹤0.01% 2937
2025
Q4 		$150K Buy
+4,765
New +$116K ﹤0.01% 3044

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

SG Americas Securities's MBX Position: Q2 2026 in Review

SG Americas Securities increased its MBX Biosciences (MBX) stake by 84% in Q2 2026, buying an estimated $99.9K and bringing the position to 6,245 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

SG Americas Securities first reported a position in MBX in Q4 2025 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • SG Americas Securities held 6,245 shares of MBX Biosciences worth $345K as of Q2 2026.
  • SG Americas Securities bought 2,859 MBX Biosciences shares in Q2 2026, an estimated $99.9K.
  • MBX Biosciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2517 holding.
  • SG Americas Securities first reported a position in MBX Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.